SAB BIOTHERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.64 USD | -.--% |
|
-2.94% | -61.60% |
| May. 30 | SAB Biotherapeutics, Inc. Announces Change of Chief Financial Officer | CI |
| May. 21 | FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics | CI |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|
| Last | 2.72 $ | 2.82 $ | 2.64 $ | 2.64 $ |
| Volume | 3 483 | 3 400 | 10 170 | 4 222 |
| Change | -.--% | +3.68% | -6.38% | -.--% |
| Opening | 2.71 | 2.72 | 2.79 | 2.64 |
| High | 2.82 | 2.82 | 2.82 | 2.64 |
| Low | 2.62 | 2.72 | 2.64 | 2.47 |
Performance
| 1 week | -2.94% | ||
| 1 month | -34.33% | ||
| 3 months | -40.14% | ||
| 6 months | -71.91% | ||
| Current year | -61.60% | ||
| 1 year | -71.20% | ||
| 3 years | -97.34% |
Volumes
marketsDaily volume
4 222
Estimated daily volume
4 222
Avg. Volume 20 sessions
41 515
Daily volume ratio
0.10
Avg. Volume 20 sessions USD
109 599.60
Record volume 1
3 712 922
Record volume 2
2 620 996
Record volume 3
1 533 516
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (USD)
24 355 304
Net sales (USD)
2 238 990
Number of employees
57
Sales / Employee (USD)
39 281
Free-Float
80.4 %
Free-Float capitalization (USD)
19 705 469
Average Daily Capital Traded
0.45%
Highs and lows
1 week
2.47
2.82
1 month
2.364.50
Current year
2.367.00
1 year
2.3610.50
3 years
2.36129.00
5 years
2.36129.00
10 years
2.36129.00
Indicators
Moving average 5 days
2.72
Moving average 20 days
3.53
Moving average 50 days
4.07
Moving average 100 days
4.78
Price spread / (MMA5)
+2.88%
Price spread / (MMA20)
+33.63%
Price spread / (MMA50)
+54.23%
Price spread / (MMA100)
+81.17%
STIM
RSI 9 days
22.43
RSI 14 days
25.30
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -2.94% | -61.60% | -71.20% | 24.36M | ||
| +1.06% | -0.49% | +11.60% | +32.46% | 106B | ||
| +1.87% | +3.76% | -4.68% | -6.96% | 24.28B | ||
| +1.04% | +0.89% | -0.82% | -7.69% | 21.96B | ||
| +0.31% | +0.55% | -10.12% | -28.84% | 18.16B | ||
| +0.41% | -1.50% | -42.12% | -37.93% | 16.37B | ||
| -3.50% | -2.53% | -17.47% | -34.53% | 15.56B | ||
| -0.91% | -2.86% | +2.77% | +46.67% | 13.63B | ||
| +4.28% | +5.12% | +34.58% | +3.69% | 12.27B | ||
| -3.39% | +150.23% | +77.64% | +181.73% | 8.87B | ||
| -1.71% | +3.60% | +7.26% | +47.97% | 7.75B | ||
| +0.09% | +2.20% | +11.89% | +38.52% | 7.65B | ||
| +0.25% | -1.43% | -3.92% | +22.05% | 7.42B | ||
| -7.66% | -3.38% | -33.51% | -36.87% | 7.29B | ||
| +0.78% | -0.78% | +234.55% | +179.44% | 6.87B | ||
| +4.40% | +5.47% | -9.57% | +13.05% | 6.32B | ||
| Average | -0.17% | +9.79% | +12.28% | +21.35% | ||
| Weighted average by Cap. | +0.41% | +5.04% | +9.01% | +19.92% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
5ea1987c08d0.C4Ld-iJ2B_jVBeVFRhcYAu4cBGaWDcTUZOcTlm_F2dw.c-uvrBQMNZq3NqQOLlxbRoMsVlX8X4GdO4JUxwWhrpQ71b7CWwdzzIROjg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 2.64 | 1,517 | 3,298 |
| 02:26:52 pm | 2.55 | 501 | 1,781 |
| 12:34:02 pm | 2.47 | 505 | 1,280 |
| 12:33:20 pm | 2.488 | 384 | 775 |
| 12:33:20 pm | 2.488 | 116 | 391 |
Monthly variations
Annual change
| 2024 | -61.60% | ||
| 2023 | +16.55% | ||
| 2022 | -92.45% | ||
| 2021 | -23.05% |
- Stock Market
- Equities
- SABS Stock
- Quotes SAB Biotherapeutics, Inc.
